Craft

Antidote

Total Funding

$40.9 M

Revenue

£7.8 M

FY, 2021

Antidote Summary

Company Summary

Overview
Antidote Technologies (formerly known as TrialReach) is a digital health company that bridging the gap between medical research and the people who need it. It offers clinical trials, which looks like a simple search tool through which patients can find a trial that is right for them by answering a few questions.
Type
Private
Status
Active
Founded
2010
HQ
London, GB | view all locations
Website
https://antidote.me/
Cybersecurity rating
Sectors

Key People

  • Laurent Schockmel

    Laurent Schockmel, Chief Executive Officer

  • Keith Lovell

    Keith Lovell, Chief Financial Officer

  • Kulvinder Maingi

    Kulvinder Maingi, Chief Technology Officer

  • Sam Veeck

Operating MetricsView all

Partners

300

Oct, 2022

Trademarks

2

Oct, 2022

LocationsView all

2 locations detected

  • London HQ

    United Kingdom

    39 Earlham St

  • New York, NY

    United States

    845 3rd Ave floor 6

Antidote Financials

Summary Financials

Revenue (FY, 2021)
£7.8M
Gross profit (FY, 2021)
£4.1M
Net income (FY, 2021)
(£1.5M)
Cash (FY, 2021)
£7.2M
EBIT (FY, 2021)
(£1.4M)

Footer menu